| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Sr. VP Clinical Dev. &CMO
2 companies
Rubin Paul D serves as a Sr. VP Clinical Dev. &CMO at XOMA and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 0 buys and 12 sells. Those positions are worth an estimated $256K at current prices.
Historically, Rubin Paul D's trades have earned a below-average insider score of 20/100 across 3 rated trades. On a 3-month view, 0.0% of the rated trades came out ahead, averaging -66.6% over three months.
The biggest single holding is XOMA (~$256K) as Sr. VP Clinical Dev. &CMO. The recent filings there lean toward selling, a net 97,124 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 23, 2015 | XOMA Xoma Royalty Corp | Sr. VP Clinical Dev. &CMO | Sell | 32,742 | $3.94 | $128,879.06 | -21.5% |